Simultaneous detection of <scp> JAK2 </scp> , <scp> CALR </scp> , and <scp> MPL </scp> mutations and quantitation of <scp> JAK2 V617F </scp> allele burden in myeloproliferative neoplasms using the quenching <scp>probe‐Tm</scp> method in i‐densy <scp>IS</scp> ‐5320-Reference-Cited by-同舟云学术

Simultaneous detection of JAK2 , CALR , and MPL mutations and quantitation of JAK2 V617F allele burden in myeloproliferative neoplasms using the quenching probe‐Tm method in i‐densy IS ‐5320

Published:2022-08-30 Issue:6 Volume:44 Page:1102-1110
ISSN:1751-5521
Container-title:International Journal of Laboratory Hematology
language:en
Short-container-title:Int J Lab Hematology

Author:

Arai Kunihito¹,Sakaguchi Masahiro¹^ORCID,Yui Shunsuke¹,Kitano Tomoaki¹,Miyata Miho¹,Yogosawa Mayumi¹,Nakayama Kazutaka²,Tajika Kenji²,Usuki Kensuke³,Kuroda Junya⁴,Uoshima Nobuhiko⁵,Kobayashi Yutaka⁵,Uchiyama Hitoji⁶,Kubota Yasushi⁷,Kimura Shinya⁷,Mori Shinichiro⁸,Hirai Mitsuharu⁹,Wakita Satoshi¹,Yamaguchi Hiroki¹^ORCID

Affiliation:

1. Department of Hematology Nippon Medical School Tokyo Japan

2. Department of Hematology Yokohama Minami Kyousai Hospital Kanagawa Japan

3. Department of Hematology NTT Medical Center Tokyo Tokyo Japan

4. Division of Hematology and Oncology Kyoto Prefectural University of Medicine Kyoto Japan

5. Department of Hematology Japanese Red Cross, Kyoto Daini Hospital Kyoto Japan

6. Department of Hematology Japanese Red Cross Kyoto Daiichi Hospital Kyoto Japan

7. Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine Faculty of Medicine, Saga University Saga Japan

8. Hemato‐Oncology Department St Luke's International Hospital Tokyo Japan

9. ARKRAY, Inc. Kyoto Japan

Publisher

Wiley

Subject

Biochemistry (medical),Clinical Biochemistry,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijlh.13938

Reference33 articles.

1. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

2. Therapeutic effects of tyrosine kinase inhibitors and subtypes of BCR-ABL1 transcripts in Japanese chronic myeloid leukemia patients with three-way chromosomal translocations

3. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

4. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis